Regeneron and Sanofi Receive Approval for Dupixent® in Japan to Treat Chronic Obstructive Pulmonary Disease (COPD)

TARRYTOWN -- Regeneron Pharmaceuticals, and Sanofi announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan ...

March 31, 2025 | Monday | News
AstraZeneca’s Calquence® Combination Therapy Recommended for EU Approval in Untreated Mantle Cell Lymphoma

AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Un...

March 31, 2025 | Monday | News
Sanofi’s mRNA Chlamydia Vaccine Candidate Receives Fast Track Designation from FDA

The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. ...

March 28, 2025 | Friday | News
Merck and Hengrui Pharma Forge $1.97 Billion Global Partnership to Advance Novel Lp(a) Inhibitor for Cardiovascular Disease

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a ...

March 26, 2025 | Wednesday | News
Cytiva Expands Xcellerex X-Platform Bioreactor Portfolio to Accelerate Advanced Therapeutics

    X-platform bioreactors are designed to help navigate challenges by combining reliability, scalability, and flexibility in one solution&...

March 26, 2025 | Wednesday | News
Rhythm Pharmaceuticals Reacquires Rights to IMCIVREE® (setmelanotide) in China, Hong Kong, and Macau

 Rhythm Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neur...

March 24, 2025 | Monday | News
Telix Pharmaceuticals' Illuccix® Receives Full ANVISA Approval for Prostate Cancer Imaging in Brazil

Telix Pharmaceuticals Limited announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approve...

March 19, 2025 | Wednesday | News
AbbVie’s Final Phase 3 MIRASOL Data Confirms 32% Reduced Risk of Death with ELAHERE in Platinum-Resistant Ovarian Cancer

Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with E...

March 17, 2025 | Monday | News
Laplace Interventional Secures Series C Financing to Advance Transcatheter Tricuspid Valve Technology

The Series C financing was led by a global strategic investor along with participation from new investors Aphelion Cardeation and Unorthodox Ventures. Ex...

March 17, 2025 | Monday | News
SK pharmteco Embarks on My Green Lab Certification to Advance Sustainable Laboratory Practices

-SK pharmteco, a global pharmaceutical subcontract development and manufacturing organization, CDMO), has just reached an important step in its sustainab...

March 14, 2025 | Friday | News
Belén Garijo Leads Merck Back to Profitable Growth, Delivering Strong 2024 Performance

  Key Financial Highlights: Full-year net sales increased to €21.2 billion (organically: +2.0%) EBITDA pre rose to €6.1 billion (orga...

March 06, 2025 | Thursday | Company results
CordenPharma Commits >€1 Billion to Expand Peptide Manufacturing Across Europe and the US

  CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and la...

March 05, 2025 | Wednesday | News
23andMe Board Rejects CEO Anne Wojcicki’s Lowball Buyout Offer, Raising Big Questions for Investors

The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed ...

March 04, 2025 | Tuesday | Analysis
SK bioscience Secures PAHO Contract Extension to Supply SKYVaricella® to Latin America Through 2027

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the compan...

February 28, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close